Jonathan Barratt, PhD, FRCP

Symptoms Management and Targeting the Root Cause of IgAN

Please discuss how clinicians can shift the treatment strategy between managing symptoms and targeting the root cause of the disease.

Videos

Biomarkers and clinical indicators play a crucial role in predicting disease outcomes, offering insights into disease progression, treatment response, and patient prognosis. These indicators can be genetic, molecular, or cellular, and are often identified through advanced diagnostic techniques. For instance, specific gene mutations or protein expressions can indicate the likelihood of disease recurrence or metastasis. Additionally, clinical indicators such as tumor size, stage, and patient health status are integral in assessing outcomes. Personalized medicine leverages these biomarkers to tailor treatment plans, enhancing therapeutic efficacy and patient survival rates.

Panelists discuss how clinicians can effectively shift treatment strategies for IgA nephropathy from merely managing symptoms to actively targeting the root causes of the disease.

Oroteinuria Reduction in Long-Term Kidney Damage Prevention

How does the reduction of proteinuria factor into the broader treatment goals for IgA nephropathy, and what evidence, if any, supports proteinuria reduction as a critical goal in preventing long-term kidney damage?

Panelists discuss how the reduction of proteinuria is integral to the broader treatment goals for IgA nephropathy, highlighting evidence that supports its role in preventing long-term kidney damage.

Proteinuria Reduction in Long-Term Kidney Damage Prevention

Primary Treatment Goals for Patients With IgAN

What are the primary treatment goals for patients with IgA nephropathy, and how do they evolve based on the stage of the disease?

Panelists discuss how the primary treatment goals for patients with IgA nephropathy evolve based on the stage of the disease, emphasizing the importance of tailoring strategies to individual patient needs.

Biomarkers and Improving IgAN Diagnostic Accuracy

What other biomarkers can be integrated with proteinuria measurements to improve diagnostic accuracy for IgA nephropathy?

Panelists discuss how integrating additional biomarkers with proteinuria measurements can enhance the diagnostic accuracy for IgA nephropathy.

Jonathan Barratt, PhD, FRCP

Articles